Due to the strain that COVID-19 has had on our healthcare system, including our infectious disease physicians, laboratory staff and regulatory agencies, we ask that all new phage therapy evaluations be put on hold indefinitely.
We will keep everyone informed when this situation changes, and we are able to resume business as usual.
Please stay healthy and practice social distancing.
June 2020 | Scientific American
February 26, 2020 | Nature Microbiology
December 13, 2019 | NIH Newsroom
November 18, 2019 | Bloomberg Businessweek
September 8, 2019 | The World to Come Podcast | Bank of America Merrill Lynch
Monday, September 2, 2019 | BBC Outlook
Tuesday, August 27, 2019 | by Peter Jaret, special to AAMCNews
Cystic Fibrosis Patients Turn to Experimental Phage Therapy - Read the New York Times article about the growing interest in using phage therapy in the treatment of cystic fibrosis.
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus - Learn how the University of Pittsburgh, the Great Ormond Street Hospital in London, and the University of California, San Diego worked together to treat a 15-year-old patient with a disseminated Mycobacterium abscessus infection and cystic fibrosis.
How to treat antibiotic-resistant superbugs: Woman saves husband with phage therapy - Dr. Steffanie Strathdee and Dr. Tom Patterson share their story with the Today Show.
Follow This: Season 3 Trailer - Watch Dr. Strathdee discuss taking on superbug infections, in Part 3, Episode 2 (Superbug Snipers) of Follow This in Netflix.
The 50 Most Influential People in Health Care of 2018 - Read about Dr. Strathdee and others, named as TIME Magazine's 50 most Influential People in Health Care.